Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
DN.3.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
DJ.1.2NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
XBC.1.5NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
CM.6NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BW.1.2NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
FW.3NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
CH.1.1.29NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.55NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.14NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.423NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.550NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.1.261NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
XBB.3.5NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
EP.1.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BQ.1.15.2NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
XCBNNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
XBB.5NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BQ.1.15.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
CM.8.1.5NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
XSNNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
FL.4.7NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
XBB.1.5.29NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.38NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.160.25NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
XBB.1.5.74NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
XBB.7NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BN.2.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
XBB.2.6.2NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.238NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
XBB.1.7NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
XBB.1.11NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BQ.1.1.68NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BR.1.2NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BQ.1.1.25NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BQ.1.1.51NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
FT.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
XBB.2.11.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.4NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.35NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
A.5NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.422NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.6NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.56NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.4.7NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.1.198NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.1.366NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.441NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.416NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.1.63NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.1.263NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used